U.S. markets open in 2 hours 56 minutes

ContraFect Corporation (CFRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.0400+0.1100 (+2.80%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Williams %R

Williams %R

Previous Close3.9300
Bid3.8600 x 2200
Ask4.2500 x 3200
Day's Range3.8700 - 4.0400
52 Week Range3.1000 - 7.6300
Avg. Volume267,414
Market Cap158.904M
Beta (5Y Monthly)0.95
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • ContraFect Corporation
    Analyst Report: Johnson & JohnsonJohnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total sales are generated in the United States.
    Fair Value
    Economic Moat
    11 days agoMorningstar
View more
  • Insider Monkey

    Were Hedge Funds Right About ContraFect Corp (CFRX)?

    In this article we will analyze whether ContraFect Corp (NASDAQ:CFRX) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas. There’s no better way to get these firms’ immense resources and analytical capabilities working for us than to follow their lead into […]

  • Simply Wall St.

    What You Need To Know About ContraFect Corporation's (NASDAQ:CFRX) Investor Composition

    The big shareholder groups in ContraFect Corporation ( NASDAQ:CFRX ) have power over the company. Large companies...

  • TipRanks

    2 “Strong Buy” Penny Stocks With Massive Upside Potential

    Of all the controversial plays on Wall Street, penny stocks take the cake. The risk-tolerant flock to these names as the potential for share prices to grow from pocket change to more than a few dollars is too tempting to ignore. That said, these tickers aren’t without their pitfalls. Some investors avoid them entirely, arguing that the bargain price tags are too good to be true. Rather, the fact that shares are trading at such low levels could reflect problems lying beneath the surface, whether